February 20, 2026

Collegium Pharmaceutical, Inc. (COLL) Stock Analysis: 18.78% Potential Upside Beckons Investors

Collegium Pharmaceutical, Inc. (NASDAQ: COLL), a formidable player in the healthcare sector, has been making waves in the specialty and generic drug manufacturing industry. This U.S.-based..

Tilray Brands, Inc. (TLRY) Stock Analysis: Potential Upside of Nearly 50% Amidst Mixed Performance Indicators

Tilray Brands, Inc. (NASDAQ: TLRY) is a prominent player in the healthcare sector, specifically within the drug manufacturing industry focusing on specialty and generic products. As..

Ginkgo Bioworks Holdings, Inc. (DNA): Investor Outlook on a Biotechnology Innovator with a 3.20% Potential Upside

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) stands as a beacon of innovation in the biotechnology sector, representing a forward-thinking approach to cell programming and biosecurity. With..

Avanos Medical, Inc. (AVNS) Stock Analysis: Navigating Challenges with a Strong Free Cash Flow

Avanos Medical, Inc. (NYSE: AVNS) operates within the healthcare sector, focusing specifically on medical devices. This Alpharetta, Georgia-based company has carved out a niche for itself..

Zevra Therapeutics, Inc. (ZVRA) Investor Outlook: Exploring a Potential 153.59% Upside

Zevra Therapeutics, Inc. (NASDAQ: ZVRA) is making waves in the biotech sector with its focus on pioneering treatments for rare diseases. With a market capitalization of..

Autolus Therapeutics plc (AUTL): Unpacking the Potential 448% Upside for Investors

Autolus Therapeutics plc (NASDAQ: AUTL) has recently captured investor attention, not just for its innovative approach in the biotechnology sector but also due to its staggering..

Fortrea Holdings Inc. (FTRE) Stock Analysis: A Potential 49% Upside Beckons Investors

Fortrea Holdings Inc. (FTRE), a prominent player within the biotechnology sector, is capturing investor attention with its promising growth prospects and strategic collaborations. Based in Durham,..

SIGA Technologies Inc. (SIGA) Stock Analysis: Intriguing Valuation Metrics Amidst Revenue Challenges

SIGA Technologies Inc. (NASDAQ: SIGA), a key player in the healthcare sector specializing in drug manufacturing, presents a curious case for investors. With a market capitalization..

Day One Biopharmaceuticals, Inc (DAWN) Stock Analysis: A Potential 91.59% Upside in the Biotechnology Sector

Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN), a dynamic player in the biotechnology sector, has recently caught the attention of investors with a potential upside of 91.59%...

Amylyx Pharmaceuticals (AMLX) Stock Analysis: A 50% Upside Opportunity in the Neurodegenerative Disease Market

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) has been capturing the attention of investors with its potential to deliver significant upside, despite its current challenges. Operating within the..

LENZ Therapeutics, Inc. (LENZ) Stock Analysis: A Promising Biotech with a 325% Potential Upside

In the dynamic world of biotechnology, few companies present as intriguing a case for investors as LENZ Therapeutics, Inc. (NASDAQ: LENZ). With its focus on developing..

OrthoPediatrics Corp. (KIDS) Stock Analysis: Exploring a 40.76% Potential Upside in Pediatric Orthopedics

OrthoPediatrics Corp. (NASDAQ: KIDS), a specialized medical device company, is making waves in the healthcare sector with its unique focus on pediatric orthopedic solutions. With a..

Maze Therapeutics, Inc. (MAZE) Stock Analysis: A Biotech with a 9.78% Upside Potential

Maze Therapeutics, Inc. (NASDAQ: MAZE) represents a compelling opportunity within the biotechnology sector, particularly for those interested in pioneering healthcare innovations. With a market capitalization of..

Simulations Plus, Inc. (SLP) Stock Analysis: Exploring a Potential 102% Upside Opportunity

Simulations Plus, Inc. (NASDAQ: SLP), a healthcare sector player specializing in health information services, is garnering attention with its potential 102% upside based on current analyst..

RxSight, Inc. (RXST) Stock Analysis: A Closer Look at the 23.68% Potential Upside

RxSight, Inc. (RXST), a notable player in the healthcare sector, is making waves in the medical devices industry with its innovative approach to enhancing cataract surgery..

Xencor, Inc. (XNCR) Stock Analysis: Exploring a Biotech Giant with 145% Upside Potential

Xencor, Inc. (NASDAQ: XNCR) is an intriguing player in the biotechnology sector, offering investors a significant upside potential of 145.60%, according to analyst ratings. With a..

Castle Biosciences, Inc. (CSTL) Stock Report: Analysts See 54.98% Potential Upside Amidst Innovative Diagnostics

Castle Biosciences, Inc. (NASDAQ: CSTL), a leader in molecular diagnostics, is making waves in the healthcare sector despite recent market fluctuations. With a market capitalization of..

Stoke Therapeutics, Inc. (STOK) Stock Analysis: Impressive Revenue Growth and Promising Upside

Stoke Therapeutics, Inc. (NASDAQ: STOK), a prominent player in the biotechnology sector, has been catching the eyes of investors, boasting a market capitalization of $1.96 billion...

HealthStream, Inc. (HSTM) Stock Analysis: Exploring a Potential 60.89% Upside in the Health Information Services Sector

HealthStream, Inc. (NASDAQ: HSTM), a stalwart in the Health Information Services industry, has been a focal point for investors eyeing the Healthcare sector. With its unique..

Vir Biotechnology (VIR) Stock Analysis: A Potential 111% Upside Amidst Strategic Collaborations

Vir Biotechnology, Inc. (NASDAQ: VIR) presents a compelling case for investors with its ambitious pipeline in the fight against infectious diseases and a significant potential upside...

Search

Funds

February 20, 2026

Search

Funds

February 20, 2026

FTSE 100

Funds